معرفی
Kanat Yalcin, MD is an Associate Research Scientist in Neurosurgery at Yale University's School of Medicine. He holds a medical degree from Istanbul Bilim University. His research focuses on genomic characterization of brain tumors, particularly meningiomas, pituitary adenomas, and intracranial aneurysms. He collaborates with prominent researchers like Murat Gunel, Ketu Mishra-Gorur, and Declan McGuone, investigating tumor biology, clinical outcomes, and molecular drivers of neurological disorders. Recent work includes genomic profiling of meningiomas across racial groups, immune mechanisms in aneurysm rupture, and AI-driven imaging analysis for glioblastoma prognosis. His contributions span over 20 peer-reviewed publications in journals like Neuro-Oncology and Journal of Neurosurgery.
Research interests emphasize translating genomic discoveries into clinical applications, such as molecular classification systems for pituitary tumors and surgical strategies informed by genetic profiles. His studies address critical questions in neuro-oncology, including tumor heterogeneity, seizure mechanisms in meningiomas, and predictive biomarkers for tumor recurrence.
Publications highlight advancements like identifying immune cell roles in aneurysm rupture, racial disparities in meningioma behavior, and novel imaging platforms for CDKN2A status prediction. His work bridges basic science and clinical practice, aiming to improve outcomes for patients with complex neurological malignancies.
